Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health.

Abstract

The use of TNFα antagonists must follow specific guidelines to ensure optimal effectiveness and safety. The French Society for Rheumatology (SFR) and Task Force on Inflammatory Joint Diseases (CRI), in partnership with several French learned societies, asked the French National Authority for Health (HAS) to develop and endorse good practice guidelines for… (More)
DOI: 10.1016/j.jbspin.2013.09.001

Topics

Cite this paper

@article{Gob2013RecommendationsFU, title={Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health.}, author={Vincent Go{\"{e}b and Marc Ardizzone and Laurent Arnaud and J{\'e}r{\^o}me Avouac and Athan C Baillet and Alexandre Belot and B{\'e}atrice Bouvard and Pascal Coquerelle and Sabrina Dadoun and Alain Diguet and David Launay and Danielle Lebouc and Pierre Loulergue and Sophie Mahy and Pascal Mestat and Ga{\"{e}l Mouterde and Benjamin Terrier and Coralie Varoquier and Mathieu Verdet and Xavier Pu{\'e}chal and Jean Sibilia}, journal={Joint, bone, spine : revue du rhumatisme}, year={2013}, volume={80 6}, pages={574-81} }